drugset / Press release
American Association for Cancer Research (AACR) Annual Meeting 2025 Poster Presentation: LB207: Continuous subcutaneous lenalidomide delivery improves the therapeutic index and avoids drug-related grade 3/4 hematologic toxicity in patients with relapsed/refractory multiple myeloma
2025-04-25 · Starton Therapeutics, Inc · original startontx.com ↗
Posted: April 25, 2025 Please view here, or download from the button below. StartonTX_AACR_2025 Download
The release as fetched from its publisher. startontx.com ↗